Related Experiment Videos
The case for high-dose chemotherapy: is it chemotherapy's last gamble?
European Journal of Cancer & Clinical Oncology
|April 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association·2001
Burnout: caring for the caregivers.
The oncologist·2000
The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.
European journal of cancer & clinical oncology·1989
Nutritional factors and cancers of the breast, endometrium and ovary.
European journal of cancer & clinical oncology·1989
Reproductive factors and cancers of the breast, ovary and endometrium.
European journal of cancer & clinical oncology·1989
Multiple primary cancers of the breast, endometrium and ovary.
European journal of cancer & clinical oncology·1989
Cancers of the breast, endometrium and ovary: geographic correlations.
European journal of cancer & clinical oncology·1989
Hormone replacement therapy in women treated for breast cancer.
European journal of cancer & clinical oncology·1989
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer control : journal of the Moffitt Cancer Center·2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal of comparative effectiveness research·2026